The influence of pericardial fat upon left ventricular function in obese females: evidence of a site-specific effect
© Hua et al.; licensee BioMed Central Ltd. 2014
Received: 1 November 2012
Accepted: 12 May 2014
Published: 23 May 2014
Although increased volume of pericardial fat has been associated with decreased cardiac function, it is unclear whether this association is mediated by systemic overall obesity or direct regional fat interactions. We hypothesized that if local effects dominate, left ventricular (LV) function would be most strongly associated with pericardial fat that surrounds the left rather than the right ventricle (RV).
Female obese subjects (n = 60) had cardiovascular magnetic resonance (CMR) scans to obtain measures of LV function and pericardial fat volumes. LV function was obtained using the cine steady state free precession imaging in short axis orientation. The amount of pericardial fat was determined volumetrically by the cardiac gated T1 black blood imaging and normalized to body surface area.
In this study cohort, LV fat correlated with several LV hemodynamic measurements including cardiac output (r = -0.41, p = 0.001) and stroke volume (r = -0.26, p = 0.05), as well as diastolic functional parameters including peak-early-filling rate (r = -0.38, p = 0.01), early late filling ratio (r = -0.34, p = 0.03), and time to peak-early-filling (r = 0.34, p = 0.03). These correlations remained significant even after adjusting for the body mass index and the blood pressure. However, similar correlations became weakened or even disappeared between RV fat and LV function. LV function was not correlated with systemic plasma factors, such as C-reactive protein (CRP), B-type natriuretic peptide (BNP), Interleukin-6 (IL-6), resistin and adiponectin (all p > 0.05).
LV hemodynamic and diastolic function was associated more with LV fat as compared to RV or total pericardial fat, but not with systemic inflammatory markers or adipokines. The correlations between LV function and pericardial fat remained significant even after adjusting for systemic factors. These findings suggest a site-specific influence of pericardial fat on LV function, which could imply local secretion of molecules into the underlying tissue or an anatomic effect, both mechanisms meriting future evaluation.
KeywordsCardiovascular magnetic resonance Obesity Pericardial fat
Recent studies of humans using a variety of approaches have suggested that regional fat distribution, rather than overall obesity plays an important role in cardiac modification [1–4]. Pericardial fat, a regional fat depot, is a metabolically active organ that secretes several bioactive proteins, including adiponectin, resistin, various inflammatory molecules, and is a rich source of free fatty acids (FFA) [5–8]. Pericardial fat could therefore exert local effects by multiple mechanisms on the underlying anatomic structures, including the heart and coronary arteries. Previous studies have linked excess pericardial fat to decreased cardiac indices, impaired diastolic filling or even congestive heart failure, and measures of cardiac structure such as left ventricular (LV) mass and left atrial size [9–11]. However, it is not clear whether the described associations between increased pericardial fat and adverse heart modifications are mediated by systemic effects caused by overall obesity or are a result of direct local interactions caused by the regional fat.
To explore which effect dominates LV modifications, we segmented and quantified fat covering the LV and the right ventricle (RV) separately to examine relationships of these specific fat depots to LV function. We hypothesized that if local effects dominate, pericardial fat surrounding the left ventricle would be associated more with measures of structure and function from the same chamber as opposed to the adjacent one. Since cardiovascular magnetic resonance (CMR) provides high spatial resolution and has the ability to perform 3D measurements, while maintaining adequate temporal resolution, it was chosen as the preferred imaging modality.
Female obese subjects (BMI ≥ 30 kg/m2, n = 60, age = 21-60 yrs) with no known cardiovascular disease were recruited from the Nutrition and Weight Management Center at Boston Medical Center with informed consent approved by the Intuitional Review Board of Boston University Medical Center. Subjects with atherosclerotic vascular disease, including those who have had stroke, myocardial infarctions, heart failure, prior percutaneous or surgical revascularization procedures, anginas, or peripheral arterial disease were excluded. In addition, subjects who weighed over 136 kg or had a waist circumference greater than 140 cm were excluded due to the size limitation of the scanner.
Subjects arrived for CMR in a fasting state (no food or liquid other than water consumed over the previous 8 hours). Height (to the nearest 0.1 cm), weight (to the nearest 0.1 kg), and waist circumference (in cm) were measured. BMI was calculated as body weight divided by height squared, and used as a marker of overall obesity. A fasting blood sample was collected by routine venipuncture, and the plasma levels of high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, triglyceride (TG), free fatty acids (FFA), fasting glucose, insulin, Interleukin-6 (IL-6), B-type natriuretic peptide (BNP), C-reactive protein (CRP), resistin and adiponectin were measured. Insulin resistance was calculated using the homeostatic model assessment (HOMA): HOMAIR = (fasting insulin (mU/l) × fasting glucose (mg/dl))/405 . The subjects underwent a CMR scan using a 3.0 T Philips Intera system (Philips Medical systems, Andover, MA). To quantify the pericardial fat volume, contiguous axial slices were obtained from the pulmonary bifurcation to the apex of the heart using an ECG gated, double inversion recovery 2D T1 weighted black blood (T1BB) sequence. The acquisition parameters were : repetition time (TR) = 2 cardiac cycles, echo time (TE) = 13 ms, number of average (NEX) = 2, sense factor = 2.5, turbo factor (TSE) = 13, field of view (FOV) = 384 × 384 mm, matrix = 256 × 256, zero filled to 512 × 512, acquired resolution = 15 × 15 mm2, reconstructed resolution = 0.75 × 0.75 mm2, slice thickness = 4 mm. In order to assess cardiac function, short axis cine CMR was performed using a steady state free precession (SSFP) sequence with 8-11 s breath holds and ECG gating. Contiguous slices were obtained from the artrio-ventricular groove to the apex of the heart. The acquisition parameters were: TR = 3.0 ms, TE =1.6 ms, NEX = 1, sense factor = 1.5, FOV = 400 × 400 mm, matrix = 256 × 256, with 26–28 heart phases acquired per slice, slice thickness = 10 mm.
Data are presented as mean ± SD. Comparisons between groups were performed using the student t-test. Associations between continuous variables were assessed using Pearson’s correlation. Multivariable adjusted linear regression was used to assess the significance of relation between the LV pericardial fat and LV function. Due to the limitation of our sample size, covariates included only BMI and the systolic blood pressure. A Two-tailed probability value p < 0.05 was defined as statistical significance.
Pericardial fat presented in the current study includes both epicardial fat (the lipid layer between the myocardium and the pericardium) and the fat external to the pericardium, as the two can generally not be separated in our measurements.
Clinic characteristics of the total study sample
Number of subjects
42.4 ± 12.0a
Body mass index, kg/m2
35.9 ± 4.6
Body surface area, m2
2.0 ± 0.17
Waist circumference, cm
105 ± 12
Systolic BPb, mmHg
123 ± 15
Diastolic BP, mmHg
79 ± 10
Total cholesterol, mg/dl
180 ± 37
Free-fatty acids, mmol/l
0.52 ± 0.23
Fasting glucose, mg/dl
102 ± 33
High density lipoprotein, mg/dl
48 ± 11
Low density lipoprotein, mg/dl
107 ± 31
103 ± 53
3.31 ± 3.36
Pericardial fat and LV function
Pearson Correlation Coefficients between Pericardial Fat and LV Function
LV function and systemic factors
Multivariable-Adjusted Regressions for LV Pericardial Fat and LV Function
To our knowledge, this is the first report indicating that the relations of LV function to LV fat are stronger than RV fat, and remain significant after the multivariable adjustment. Meanwhile, no association was observed between LV function and systemic factors including plasma inflammatory markers and adipokines. These findings suggest that pericardial fat may exert local endocrine or anatomic effects on LV function.
Obesity, defined as BMI > 30 kg/m2, has been well established as an independent risk factor for cardiovascular diseases [14, 15]. However, some recent studies suggested that regional fat distribution rather than the total amount contributes to obesity-related adverse modifications [16–21]. Among various regional fat depots, pericardial fat is of particular interest and has been proposed as a superior indicator of cardiac function because of the anatomic vicinity. Iacobellis et al.  studied 30 morbidly obese subjects and compared with 20 lean control volunteers using 2D echocardiography. They found an increase in the epicardial fat thickness strongly correlated with the decrease of LV diastolic function. Ruberg et al.  reported the negative correlations between pericardial fat and LV CO/SV in an obese group with metabolic syndrome. Both studies suggested local interactions between the regional adipose and LV function, but without ruling out the influence from systemic effects caused by overall obesity. It became particular interesting when Fox et al. performed a large population study  in 2009. They reported that pericardial fat correlated with LV EDV and atrial dimension, but these correlations did not hold after the multivariable adjustment for overall adiposity, and suggested that systemic influences might override local effects. This study  did not examine the specific LV function as the previous two [9, 10]. However, the same rationale might apply, which is the previously observed relations between the local fat and cardiac function [9, 10] may actually be the carryover effect from overall obesity.
To address this issue, we examined the relations between pericardial fat and LV function from different aspects and found novel results for our obese subjects (BMI: 30.0-46.5 kg/m2). Firstly, dissociation was observed between pericardial fat and BMI, indicating that regional fat accumulation can deviate from total body fat accumulation. In other words, it is possible to find obese subjects with “normal” amount of pericardial fat, which may not carry the pathologic influences from distal fat if local effects dominate. Secondly, LV function did not correlate with serum biomarkers, including IL-6, CRP, BNP, resistin and adiponectin. These biomarkers have been found elevated/decreased in obese people, and linked to the increased inflammatory stress, which in turn could be detrimental to cardiac function [23–27]. The lack of correlation between LV function and these serum markers suggests if endocrine effects of adiposity exist, it is likely come majorly from the local fat instead of distal fat accumulation. Finally, we have refined the measurement of the local fat, by segmenting pericardial fat overlaying different ventricles, then correlating to LV function separately. LV fat showed a consistent stronger correlation pattern to LV function, as compared with RV fat in our study cohort. In particular, the hemodynamic function of LV negatively correlated with LV but not RV fat. The increase of LV fat was also related to significant and stronger reductions of LV diastolic function, including the decreases of E-rate, E/A, and the prolonged TEF, as compared with RV fat. Moreover, most of the significant relations between LV fat and LV function still remained significant even after adjusting for two major reported confounders: BMI and the blood pressure. Since the left and right ventricles are under the same systemic influences, the additional associations between LV function and LV fat compared to RV fat suggests the local effects of pericardial fat on LV function. Although the detailed mechanisms remain to be clarified, it is possible that LV fat exerts direct anatomic pressure or elaborates FFA, resistin and other adipokines through coronary arteries, which branch off and feed the left and the right ventricles separately. In such a case, LV fat would show a stronger correlation to LV function as compared to RV fat, which does not contact or supply blood to the left ventricle directly.
In this study cohort, subjects with severe cardiac dysfunction were excluded, and late stage diastolic dysfunction with pseudonormal diastolic pattern is not likely to occur. Hence, it is reasonable to believe only linear relationship may exist between LV diastolic function and pericardial fat. In this study cohort, LV diastolic indices showed correlations with RV fat, but to a lesser extent as compared with LV fat. This observation may not necessarily suggest that RV fat has a direct influence on LV relaxation, as it could result from the strong correlation between the two fat depots in volume. This evidence implies that LV diastolic function may be impaired to a greater extent by the presence of the local adipose tissue. Various studies [28, 29] have reported that subjects with impaired diastolic filling may still have normal contractility, suggesting that the development of diastolic abnormalities generally precedes the systolic dysfunction. Similarly, our data showed that LV fat strongly correlated with several diastolic indices; however, no correlation was observed between pericardial fat and the contractile measurement, ejection fraction. Several mechanisms have been proposed to explain the early influences on LV diastolic function. Fox et al.  suggested a mechanical role of pericardial fat in diastolic dysfunction. The compression force generated by local adiposity might affect LV relaxation and induce atrial dilation. In addition, the adipose tissue around the heart is a metabolically active organ that secretes FFA, resistin and other adipokines, which are strongly linked with insulin resistance [5, 30]. Insulin resistance may affect ventricular relaxation by impairing the myocardial actin-myosin dissociation through increased intracellular Ca2+levels, because of reduced activity of Na+/K+ ATP-ase in the plasma membrane or decreased reuptake of Ca2+ into the sarcoplasmic reticulum [31, 32].
Strengths and limitations
The 3D volumetric assessment of pericardial fat and LV function provides an advantage over previous studies that used the fat thickness for similar assessments. Additionally, by considering left ventricular fat separately from the adjacent pericardial fat, we were able to more accurately describe the relationship between cardiac function and regional fat depots. Some limitations warrant discussion. In particular, epicardial fat is more proximal to the myocardium and has a different metabolic activity than the fat outside the pericardium , which theoretically would make epicardial fat a more interesting target to investigate. We were unable to distinguish the epicardial fat in all subjects, so the observed associations are partly contributed by the fat outside the pericardium. However, a previous study showed that epicardial and pericardial fat depots are highly correlated in volume (r = 0.92, p < 0.0001) in a group of randomly selected 159 subjects . Similarly, we were able to separate the two fat depots in images of 13 subjects, for whom epicardial fat was strongly correlated with pericardial fat (r = 0.92, p < 0.001, the 95% confidence interval of r: 0.76 ~ 0.98). This suggests that in our subjects, epicardial fat may have a similar relationship as seen between pericardial fat and cardiac function. Also, compared to echocardialography studies, cine- CMR has a relatively low temporal resolution of 28-30 ms, which does not allow capture of some important parameters that measure the delay in diastolic dysfunction, such as isovolumic relaxation time (IVRT). In addition, the current study was cross-sectional in design and cannot infer causality. Furthermore, the size limitation of our closed bore CMR scanner necessitated exclusion of male subjects, who tend to have large waist circumferences. Male subjects with larger BMI will be an important group for future studies with appropriate CMR scanners. Finally, obstructive sleep apnea or female specific medical conditions, such as polycystic ovarian syndrome, menopause and may have an influences on the cardiac outcomes. These more complicated conditions were not considered in the current work and would require studies with larger sample sizes.
Variation in LV hemodynamics and diastolic function, independent of body size or blood pressure, was observed that related specifically to the volume of pericardial fat overlaying the LV. Variation did appeared to associated to a lesser degree with fat overlying the RV, but was independent of serum inflammatory markers or adipokines in this healthy but obese population. These findings provide insight into a possible mechanism by which metabolic disease, and pericardial fat accumulation, might negatively impact cardiac function.
We thank Dr. Ronald J. Killiany, Director of the Center of Biomedical Imaging, Boston University and Andrew Ellison for their excellent technical assistance.
- Iacobellis G, Corradi D, Sharma AM: Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005, 2: 536-43. 10.1038/ncpcardio0319.View ArticlePubMedGoogle Scholar
- Krumholz HM, Larson M, Levy D: Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995, 25: 879-84. 10.1016/0735-1097(94)00473-4.View ArticlePubMedGoogle Scholar
- Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F: Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol. 2004, 94: 1084-7. 10.1016/j.amjcard.2004.06.075.View ArticlePubMedGoogle Scholar
- Nakajima T, Fujioka S, Tokunaga K, Matsuzawa Y, Tarui S: Correlation of intraabdominal fat accumulation and left ventricular performance in obesity. Am J Cardiol. 1989, 64: 369-73. 10.1016/0002-9149(89)90537-7.View ArticlePubMedGoogle Scholar
- Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, Gallo P, di Gioia CRT: Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005, 29: 251-5.PubMedGoogle Scholar
- Baker AR, Silva NFD, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, McTernan PG: Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006, 5: 1-10.1186/1475-2840-5-1.PubMed CentralView ArticlePubMedGoogle Scholar
- Marchington JM, Mattacks CA, Pond CM: Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B. 1989, 94: 225-32. 10.1016/0300-9629(89)90540-9.View ArticlePubMedGoogle Scholar
- Marchington JM, Pond CM: Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes Relat Metab Disord. 1990, 14: 1013-22.Google Scholar
- Ruberg FL, Chen Z, Hua N, Bigornia S, Guo Z, Hallock K, Jara H, LaValley M, Phinikaridou A, Qiao Y, Viereck J, Apovian CM, Hamilton JA: The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome. Obesity (Silver Spring). 2010, 18: 1116-21. 10.1038/oby.2009.363.View ArticleGoogle Scholar
- Iacobellis G, Leonetti F, Singh N, Sharma AM: Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol. 2007, 115: 272-3. 10.1016/j.ijcard.2006.04.016.View ArticlePubMedGoogle Scholar
- Doesch C, Haghi D, Flüchter S, Suselbeck T, Schoenberg SO, Michaely H, Borggrefe M, Papavassiliu T: Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson. 2010, 12: 40-10.1186/1532-429X-12-40.PubMed CentralView ArticlePubMedGoogle Scholar
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-9. 10.1007/BF00280883.View ArticlePubMedGoogle Scholar
- Salvado O, Hillenbrand C, Zhang S, Wilson DL: Method to correct intensity inhomogeneity in MR images for atherosclerosis characterization. IEEE Trans Med Imaging. 2006, 25: 539-52.View ArticlePubMedGoogle Scholar
- Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS: Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011, 123: e18-209. 10.1161/CIR.0b013e3182009701.PubMed CentralView ArticlePubMedGoogle Scholar
- Stoddard MF, Tseuda K, Thomas M, Dillon S, Kupersmith J: The influence of obesity on left ventricular filling and systolic function. Am Heart J. 1992, 124: 694-9. 10.1016/0002-8703(92)90280-9.View ArticlePubMedGoogle Scholar
- Ibrahim MM: Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010, 11: 11-8. 10.1111/j.1467-789X.2009.00623.x.View ArticlePubMedGoogle Scholar
- Aronne LJ, Segal KR: Adiposity and fat distribution outcome measures: assessment and clinical implications. Obes Res. 2002, 10 (Suppl 1): 14S-21.View ArticlePubMedGoogle Scholar
- Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM: Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 1989, 83: 1168-73. 10.1172/JCI113997.PubMed CentralView ArticlePubMedGoogle Scholar
- Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE: Abdominal adiposity and coronary heart disease in women. JAMA. 1998, 280: 1843-8. 10.1001/jama.280.21.1843.View ArticlePubMedGoogle Scholar
- Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE: Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study. J Epidemiol. 1997, 145: 614-9. 10.1093/oxfordjournals.aje.a009158.View ArticleGoogle Scholar
- Gillum RF, Mussolino ME, Madans JH: Body fat distribution, obesity, overweight and stroke incidence in women and men–the NHANES I Epidemiologic Follow-up Study. Int J Obes Relat Metab Disord. 2001, 25: 628-38. 10.1038/sj.ijo.0801590.View ArticlePubMedGoogle Scholar
- Fox CS, Gona P, Hoffmann U, Porter SA, Salton CJ, Massaro JM, Levy D, Larson MG, D’Agostino RB, O’Donnell CJ, Manning WJ: Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation. 2009, 119: 1586-91. 10.1161/CIRCULATIONAHA.108.828970.PubMed CentralView ArticlePubMedGoogle Scholar
- Frankel DS, Vasan RS, D’Agostino RB, Benjamin EJ, Levy D, Wang TJ, Meigs JB: Resistin, adiponectin, and risk of heart failure the Framingham offspring study. J Am Coll Cardiol. 2009, 53: 754-62. 10.1016/j.jacc.2008.07.073.PubMed CentralView ArticlePubMedGoogle Scholar
- McManus DD, Lyass A, Ingelsson E, Massaro JM, Meigs JB, Aragam J, Benjamin EJ, Vasan RS: Relations of Circulating Resistin and Adiponectin and Cardiac Structure and Function: the Framingham Offspring Study. Obesity (Silver Spring). 2012, 20 (9): 1882-6. 10.1038/oby.2011.32.View ArticleGoogle Scholar
- Berg AH, Scherer PE: Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005, 96: 939-49. 10.1161/01.RES.0000163635.62927.34.View ArticlePubMedGoogle Scholar
- Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PWF, D’Agostino RB: Framingham Heart Study: Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003, 107: 1486-91. 10.1161/01.CIR.0000057810.48709.F6.View ArticlePubMedGoogle Scholar
- Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004, 350: 655-63. 10.1056/NEJMoa031994.View ArticlePubMedGoogle Scholar
- de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH: Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol. 1994, 23: 1444-51. 10.1016/0735-1097(94)90390-5.View ArticlePubMedGoogle Scholar
- Yalçin F, Kaftan A, Muderrisoğlu H, Korkmaz ME, Flachskampf F, Garcia M, Thomas JD: Is Doppler tissue velocity during early left ventricular filling preload independent?. Heart. 2002, 87: 336-9. 10.1136/heart.87.4.336.PubMed CentralView ArticlePubMedGoogle Scholar
- Iacobellis G, Leonetti F: Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab. 2005, 90: 6300-2. 10.1210/jc.2005-1087.View ArticlePubMedGoogle Scholar
- Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Di Mario U, Leonetti F: Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res. 2002, 10: 767-73. 10.1038/oby.2002.104.View ArticlePubMedGoogle Scholar
- Mureddu GF, Greco R, Rosato GF, Cella A, Vaccaro O, Contaldo F, de Simone G: Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity. Int J Obes Relat Metab Disord. 1998, 22: 363-8. 10.1038/sj.ijo.0800596.View ArticlePubMedGoogle Scholar
- Iacobellis G: Epicardial and pericardial fat: close, but very different. Obesity (Silver Spring). 2009, 17: 625-10.1038/oby.2008.575. author reply 626–7View ArticleGoogle Scholar
- Ding J, Hsu F-C, Harris TB, Liu Y, Kritchevsky SB, Szklo M, Ouyang P, Espeland MA, Lohman KK, Criqui MH, Allison M, Bluemke DA, Carr JJ: The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2009, 90: 499-504. 10.3945/ajcn.2008.27358.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.